Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.61 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.61 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7522729 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL7515147 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL2877290 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL5812678 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL509990 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL9773213 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL7519047 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL1683717 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL7522764 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL7517294 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025132660-A1 | METHOD FOR TREATING HUMAN PERSPIRATION, AND ASSOCIATED COMPOSITION | L'OREAL (FR) | 2025-06-26 | — | — | WO | disclosed |
| US-20250009621-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2025-01-09 | — | — | US | disclosed |
| WO-2025006991-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2025-01-02 | — | — | WO | disclosed |
| CN-109593045-A | A kind of preparation method of 11- aminoundecanoic acid | 北京旭阳科技有限公司 | 2019-04-09 | — | — | CN | disclosed |
| EP-1405841-B1 | PROCESS FOR PREPARATION OF 2-OXOCARBOXYLIC ACID ESTERS | KURARAY CO (JP) | 2006-08-16 | — | — | EP | disclosed |
| US-6897335-B2 | Process for preparation of 2-oxocarboxylic acid esters | KURARAY CO., LTD. (JP) | 2005-05-24 | — | — | US | disclosed |
| US-20040162441-A1 | Process for preparation of 2-oxocarboxylic acid esters | KURARAY CO., LTD. (JP) | 2004-08-19 | — | — | US | disclosed |
| EP-1405841-A1 | PROCESS FOR PREPARATION OF 2-OXOCARBOXYLIC ACID ESTERS | KURARAY CO., LTD. (JP) | 2004-04-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250009621-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | EBP, ADH1A, ADH1C | GPR84 205/4885FFAR1 234/4885ZDHHC7 1572/4885 |
| US-20040162441-A1 | Process for preparation of 2-oxocarboxylic acid esters | HAO2, HACL2, HAO1 | GPR84 3700/4885FFAR1 298/4885ZDHHC7 633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.